Home » Stocks » PAHC

Phibro Animal Health Corporation (PAHC)

Stock Price: $21.57 USD 0.72 (3.45%)
Updated Feb 26, 2021 4:00 PM EST - Market closed
After-hours: $21.58 +0.01 (0.05%) Feb 26, 5:42 PM
Market Cap 877.03M
Revenue (ttm) 797.97M
Net Income (ttm) 44.25M
Shares Out 40.45M
EPS (ttm) 1.09
PE Ratio 19.79
Forward PE 20.79
Dividend $0.48
Dividend Yield 2.23%
Trading Day February 26
Last Price $21.57
Previous Close $20.85
Change ($) 0.72
Change (%) 3.45%
Day's Open 20.95
Day's Range 20.72 - 21.91
Day's Volume 304,409
52-Week Range 16.17 - 28.04

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
Business Wire - 2 weeks ago

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (NASDAQ:PAHC) announced it will participate in the Barclays Virtual Global Healthcare Conference. Chairman, President and Chief...

Business Wire - 2 weeks ago

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (NASDAQ:PAHC) announced it will participate in the Bank of America Merrill Lynch 2021 Virtual Animal Health Summit. Chairman, P...

Zacks Investment Research - 3 weeks ago

PAHC vs. RMD: Which Stock Is the Better Value Option?

Other stocks mentioned: RMD
Zacks Investment Research - 3 weeks ago

Phibro's (PAHC) second-quarter revenue declined 3.7% year over year to $206.1 million and gross profit improved 33%.

Business Wire - 3 weeks ago

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (NASDAQ:PAHC) today announced financial results for its second quarter ended December 31, 2020. Highlights for the December 31,...

Business Wire - 3 weeks ago

TEANECK, N.J.--(BUSINESS WIRE)--The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock...

Zacks Investment Research - 1 month ago

PAHC vs. SRDX: Which Stock Is the Better Value Option?

Other stocks mentioned: SRDX
Zacks Investment Research - 1 month ago

Phirbo's (PAHC) net vaccine sales remain robust on higher international demand for poultry vaccines.

Business Wire - 1 month ago

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (NASDAQ:PAHC) expects to announce its second quarter financial results on Wednesday, February 3, 2021, after the market closes....

Seeking Alpha - 2 months ago

Phibro was hit by the COVID-19 pandemic in FY 2020, but did show an acceptable net income and free cash flow. It shouldn't be too easy for Phibro to beat its 2020 results, and the Q1 results a...

Investopedia - 2 months ago

These are the pharmaceutical stocks with the best value, fastest growth, and most momentum for Q1 2021.

Other stocks mentioned: AMPH, AMRX, BIIB, HZNP, SUPN
Zacks Investment Research - 2 months ago

Phibro (PAHC) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research - 3 months ago

Lower sales of Phibro's (PAHC) Performance Products arm's copper-based products raise concerns.

Seeking Alpha - 3 months ago

Phibro Animal Health Corporation (PAHC) CEO Jack Bendheim on Q1 2021 Results - Earnings Call Transcript

Zacks Investment Research - 3 months ago

Phibro's (PAHC) core Animal Health segment, along with strength in Nutritional Specialties and Vaccines, boosted Q1 performance despite pandemic-led business disruptions.

Business Wire - 3 months ago

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (NASDAQ:PAHC) today announced its financial results for its first quarter ended September 30, 2020. Highlights for the Septembe...

Business Wire - 3 months ago

TEANECK, N.J.--(BUSINESS WIRE)--The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock...

Zacks Investment Research - 3 months ago

PAHC vs. RMD: Which Stock Is the Better Value Option?

Other stocks mentioned: RMD
Business Wire - 4 months ago

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (NASDAQ:PAHC) announced today it will participate in the 29th Annual Credit Suisse Virtual Healthcare Conference. Chairman, Pre...

Business Wire - 4 months ago

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (NASDAQ:PAHC) expects to announce its first quarter financial results on Wednesday, November 4, 2020, after the market closes. ...

Zacks Investment Research - 5 months ago

Phibro (PAHC) reported earnings 30 days ago. What's next for the stock?

Business Wire - 5 months ago

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (the “Company” or “Phibro”) today announced that Richard Johnson, Phibro’s Chief Financial Officer, has informed the Company th...

Business Wire - 5 months ago

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (NASDAQ:PAHC) announced today it will participate in the Morgan Stanley Virtual Annual Global Healthcare Conference.

Zacks Investment Research - 5 months ago

Phirbo (PAHC) catered industries face issues like lack of processing availability and sudden drop in demand.

Seeking Alpha - 5 months ago

Phibro Animal Health Corporation (PAHC) CEO Jack Bendheim on Q4 2020 Results - Earnings Call Transcript

Zacks Investment Research - 5 months ago

Phibro's (PAHC) core Animal Health segment was aided by the Osprey Biotechnics acquisition despite a dismal overall performance in Q4 due to pandemic-led business disruptions.

Business Wire - 6 months ago

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (NASDAQ:PAHC) today announced its financial results for its fourth quarter and fiscal year ended June 30, 2020.

Business Wire - 6 months ago

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (NASDAQ:PAHC) expects to announce its fourth quarter and fiscal year 2020 financial results on Wednesday, August 26, 2020, afte...

Business Wire - 6 months ago

TEANECK, N.J.--(BUSINESS WIRE)--The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock...

Business Wire - 7 months ago

TEANECK, N.J.--(BUSINESS WIRE)--(NASDAQ:PAHC) Today, the Food and Drug Administration (FDA) provided notice of Federal Register publication of its intention to take a number of actions related...

The Motley Fool - 8 months ago

Spending on pet health continues to climb. Investors should consider buying PetMed Express, Phibro Animal Health, and Merck & Co.

Other stocks mentioned: MRK, PETS
Zacks Investment Research - 9 months ago

Phibro (PAHC) witnessed revenue uptick in its core Animal Health segment in Q3 despite the coronavirus-led business disruptions in the animal production industry.

Seeking Alpha - 9 months ago

Phibro Animal Health Corporation (PAHC) CEO Jack Bendheim on Q3 2020 Results - Earnings Call Transcript

Zacks Investment Research - 10 months ago

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to th...

Zacks Investment Research - 11 months ago

Phibro (PAHC) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research - 1 year ago

PRGO vs. PAHC: Which Stock Is the Better Value Option?

Other stocks mentioned: PRGO
The Motley Fool - 1 year ago

The company raised guidance, and also raised hopes about its vaccine candidate for African swine fever.

Seeking Alpha - 1 year ago

Phibro Animal Health Corporation (PAHC) CEO Jack Bendheim on Q2 2020 Results - Earnings Call Transcript

Zacks Investment Research - 1 year ago

Phibro (PAHC) witnessed revenue decline in two of its core segments and contraction in operating margin in Q2.

Zacks Investment Research - 1 year ago

PRGO vs. PAHC: Which Stock Is the Better Value Option?

Other stocks mentioned: PRGO
Zacks Investment Research - 1 year ago

Investors can retain Phibro (PAHC) stock for now, thanks to its solid prospects.

Zacks Investment Research - 1 year ago

Phibro (PAHC) reported earnings 30 days ago. What's next for the stock?

Seeking Alpha - 1 year ago

Phibro Animal Health Corporation (PAHC) CEO Jack Bendheim on Q1 2020 Results - Earnings Call Transcript

Zacks Investment Research - 1 year ago

Phibro (PAHC) exhibits a dismal first-quarter performance on a decline in revenues at core business segments.

Zacks Investment Research - 1 year ago

Per Phibro Animal (PAHC), weak demand in Animal Health business due to swine flu outbreak in China along with an unfavorable product mix in Mineral Nutrition is dampening.

Zacks Investment Research - 1 year ago

Phibro (PAHC) reported earnings 30 days ago. What's next for the stock?

The Motley Fool - 1 year ago

The company will not slow investment despite a rough patch caused by African swine fever.

The Motley Fool - 1 year ago

Despite a nice move higher for the major benchmarks, these stocks missed out on the rally.

Other stocks mentioned: ADSK, MOV
Seeking Alpha - 1 year ago

Phibro Animal Health Corporation (PAHC) CEO Jack Bendheim on Q4 2019 - Earnings Call Transcript

Zacks Investment Research - 1 year ago

Phibro's (PAHC) revenue decline across two core segments and contraction in operating margin are concerning.

About PAHC

Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for livestock primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its animal health products also comprise antibacterials that are biological or chemical products used in the animal health industr... [Read more...]

Industry
Drug Manufacturers-Specialty & Generic
IPO Date
Apr 11, 2014
CEO
Jack Bendheim
Employees
1,700
Stock Exchange
NASDAQ
Ticker Symbol
PAHC
Full Company Profile

Financial Performance

In 2020, PAHC's revenue was $800.35 million, a decrease of -3.34% compared to the previous year's $828.00 million. Earnings were $33.55 million, a decrease of -38.68%.

Financial Statements

Analyst Forecasts

According to 6 analysts, the average rating for PAHC stock is "Hold." The 12-month stock price forecast is 20.00, which is a decrease of -7.28% from the latest price.

Price Target
$20.00
(-7.28% downside)
Analyst Consensus: Hold